Public, NASDAQ:ONTY
NASDAQ Global Market
Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
Date: Tue, 17 Jun 2008 12:41:40 GMT
Tags:
Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
PR Newswire (press release) - Jun 17, 2008
PR Newswire (press release) - Jun 17, 2008
BELLEVUE , WA , June 17 / PRNewswire - FirstCall / - Oncothyreon Inc . ( Nasdaq : ONTY ) ( TSX : ONY ) today announced enrollment of the first patient in a Phase 1 trial of PX - 866 in patients ...
Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
Date: Wed, 11 Jun 2008 12:47:07 GMT
Tags:
Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
istockAnalyst.com - Jun 11, 2008
istockAnalyst.com - Jun 11, 2008
BELLEVUE , WA , June 11 / PRNewswire - FirstCall / - Oncothyreon Inc . ( Nasdaq : ONTY ) ( TSX : ONY ) ( the ' Company ' ) today announced that the first patient hasbeen treated in a Phase 1b ...
Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
Date: Wed, 11 Jun 2008 12:44:18 GMT
Tags:
Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
PR Newswire (press release) - Jun 11, 2008
PR Newswire (press release) - Jun 11, 2008
BELLEVUE , WA , June 11 / PRNewswire - FirstCall / - Oncothyreon Inc . ( Nasdaq : ONTY ) ( TSX : ONY ) ( the " Company " ) today announced that the first patient has been treated in a Phase 1b ...
Oncothyreon announces appointments to board of directors
Date: Mon, 09 Jun 2008 12:14:46 GMT
Tags:
Oncothyreon announces appointments to board of directors
Canada NewsWire (press release) - Jun 9, 2008
Canada NewsWire (press release) - Jun 9, 2008
BELLEVUE , WA , June 9 / CNW / - Oncothyreon Inc . ( Nasdaq : ONTY ) ( TSX : ONY ) ( the " Company " ) today announced that Daniel K . Spiegelman and Stephen K . Burley , MD , D . Phil . have ...
Stimuvax Phase 1/2 survival data support prior results
Date: Mon, 02 Jun 2008 13:48:51 GMT
Tags:
Stimuvax Phase 1/2 survival data support prior results
FOXBusiness - Jun 2, 2008
FOXBusiness - Jun 2, 2008
BELLEVUE , WA , Jun 2 , 2008 ( Canada NewsWire via COMTEX ) - - - - Oncothyreon Inc . ( Nasdaq : ONTY ) ( TSX : ONY ) today announced the presentation of two - year survival data from a Phase ...
CIT Group, Oncothyreon: Biggest Price Gainers (CIT, ONTY) (at The Wall Street Journal Online)
Date: Tue, 1 Jul 2008 20:29:00 Etc/GMT
Tags:
Oncothyreon initiates Phase 1 trial of PX-866 cancer compound (PR Newswire)
Date: Tue, 17 Jun 2008 12:00:00 Etc/GMT
Tags:
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1 trial of PX-866 in patients with advanced solid tumors. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase , an important cell survival signaling pathway.
Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer (PR Newswire)
Date: Wed, 11 Jun 2008 12:00:00 Etc/GMT
Tags:
Oncothyreon Inc. today announced that the first patient has been treated in a Phase 1b clinical trial of PX-12 in patients with advanced metastatic cancer. PX-12 is a proprietary small molecule inhibitor of thioredoxin, a protein that regulates diverse molecular pathways that contribute to the growth, survival and drug resistance of many cancers.
ONCOTHYREON INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements an (EDGAR Online)
Date: Mon, 9 Jun 2008 19:46:28 Etc/GMT
Tags:
Oncothyreon announces appointments to board of directors (PR Newswire)
Date: Mon, 9 Jun 2008 12:00:00 Etc/GMT
Tags:
Oncothyreon Inc. today announced that Daniel K. Spiegelman and Stephen K. Burley, M.D., D.Phil. have joined its board of directors for three-year terms. The Company also announced the retirement of S.